Navigation Links
Lack of political will and the subordination of women are major barriers to tackling AIDS
Date:2/21/2008

Denial, myths, complacency, lack of political will and the subordination of women are major obstacles in the fight against HIV and AIDS. And with no cure or vaccine in sight, scaling up prevention is of paramount importance, according to Professor Lars Kallings, a leading expert in the global fight against the worlds first modern pandemic.

Writing in Marchs Journal of Internal Medicine Professor Kallings says that: Trust in modern science is so great that people dont like to consider the thought that it may not be possible to find a simple medical way to eradicate the virus. As a result, not enough attention is given to the social and economic aspects of HIV and AIDS and the fight against discrimination factors that are vital if we are to respond to this epidemic.

Professor Kallings says that the subordination of young girls and women, and the contempt they are shown in many countries, is the major cause of the epidemic.

Many women are not able to say no to unwanted sex or ask their husbands to use condoms or be faithful he says. Stigmatisation of women is another major issue, with many not daring to be tested or treated in case they are thrown out by their families, beaten or even killed.

Professor Kallings is eminently well qualified to comment. Currently the UN Secretary-Generals Special Envoy for AIDS in Eastern Europe and Central Asia, a post he has held since 2003, he was also the founding President of the International AIDS Society in 1988 and its Secretary-General from 1994 to 2002.

His paper provides a detailed and often controversial analysis of the last 25 years, highlighting political and religious barriers and conspiracy theories, together with key medical advances.

Money is no longer the main obstacle to treating the virus, as the cost has dramatically fallen in recent years he says. However, by 2010 a massive 42 billion US dollars will need to be spent to meet the goal of universal access to
'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Blackwell Publishing Ltd.
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
2. Political decisions harming cancer treatment in Europe
3. Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E
4. Fair Political Practices Commission Will Investigate Stem Cell Conflict of Interest
5. National Institute on Drug Abuse Director Nora Volkow Speaks about the Dangers of Narcotics on Azteca Americas Political Forum Issues: Caras y Voces
6. Poll finds Americans split by political party over views on socialized medicine
7. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
8. Work-Family Conflict Dogs Air Force Women After Deployment
9. Work-Family Conflict Dogs Air Force Women After Deployment
10. Antioxidant Supplements May Raise Womens Skin Cancer Risk
11. Early Weight Loss in Women Linked to Dementia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... new study by researchers from the Medical College of ... utilization for pain and other sickle cell disease complications ... of both providers and patients were also identified. ... assistant professor of pediatrics at the Medical College and ... will be presented at the American Society of Hematology ...
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/5/2009)... in a phase 1/2 clinical trial that it ... patients newly diagnosed with multiple myeloma, a cancer of ... Dana-Farber Cancer Institute. , Partial responses or better were ... the drug combination in the multi-center study, with 74 ... the phase 2 population, reports Paul G. Richardson, MD, ...
(Date:12/5/2009)... Babies, This Type of Blood Cancer Is Most Challenging-- ... Pediatric oncologists have identified specific genes, dubbed partner ... often-fatal form of leukemia in infants. By more accurately ... which infants may benefit from particular treatments. ,, ...
(Date:12/5/2009)... Center helps companies develop and test their cleaning processes. The technology ... of industries and solve problems for customers relating to cleaning parts, ... ... 2009 -- Midbrook, Inc , a Jackson, MI-based company, is ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... According to a recent study conducted by researchers at ... lead to a rise of certain// chemicals in the ... brain and nerve cell damage. This increase of chemicals ... and symptoms of lasting neurological damage. ,This ...
... published in PLoS Medicine online says that the life expectancy ... an Asian-American woman may live// two decades longer than an ... evidence is really quite clear that most of the gap ... young and middle-aged adult men and women and most of ...
... Sreemathy today visited the community health centre at Vizhinjam and ... of viral fever//. ,"In Tamil Nadu, the number ... managed to prevent the fever spreading further along the coast," ... day in August, but on Saturday the number was just ...
... the safest pain medication? Many people with osteoarthritis ... the painkillers called COX-2 inhibitors// to increased heart ... from a COX-2 drug to other medications, including ... and naproxen. But although NSAIDs are effective at ...
... the positive influence of having a baby and its benefits ... this research seem to suggest that women who are childless ... lives and may even face early death. ,According ... age are 20% more likely to die than their contemporaries, ...
... saw the conclusion of the first of a wave of ... as Wyeth defended// its hormone replacement therapy Prempro against claims ... ,Zoe Littlepage, an attorney for plaintiff Linda Reeves, told the ... was negligent in not testing the drug and not knowing ...
Other Medicine News:Health News:Punch-Drunk Effect- Every blow matters 2
(Date:12/4/2009)... Dynatronics Corporation (Nasdaq: DYNT ) announced it ... equipment and rehab supplies to Benchmark Physical Therapy with ... "We are pleased to be named the sole-source supplier ... vice president of sales and marketing at Dynatronics. "Benchmark ...
(Date:12/4/2009)... Chemistry World recently highlighted a new ... of America ( PhRMA ) that identifies 97 new ... ,, The report found that the 97 products ... are either in human clinical trials or awaiting approval by ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... chemical threats, announced today that the Company is ... of Valortim® in an inhalation anthrax model in ... data are being presented during an oral session ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 49639 1Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 49639 2Crown Consumer Brands Re Launches DentaBurst 28TM 29 Freshening Teeth Cleaners 49636 1Crown Consumer Brands Re Launches DentaBurst 28TM 29 Freshening Teeth Cleaners 49636 2MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang 21 49633 1MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang 21 49633 2
... studies are few, NEW YORK, Aug. 13 ... a limited amount of clinical research exists,to prove ... study is published in the July/August 2007 issue ... of the,American Society for Aesthetic Plastic Surgery (ASAPS). ...
... Aug. 14 Immtech Pharmaceuticals,Inc. (Amex: IMM ... in Nucleic,Acids Research by a group of researchers ... furamidine to inhibit a key enzyme involved in ... the active metabolite (DB75),of Immtech,s proprietary, orally bioavailable ...
Other Medicine Technology:OTC Anti-Aging Products: Hype or Hope? 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 3
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
... I is an ideal first ... use by smaller laboratories, it ... economical set-up station for larger ... of other Bactron models are ...
Designed for larger laboratories or research applications, the Concept 1000 boasts some very unique features....
... is a fast, automated system for ... of microaerophilic organisms.Designed for the cost ... runs at 1% of the cost ... suitable for growth of specimens such ...
Medicine Products: